Table 2.
Study Visit | Cannabis Withdrawal | Effect Size ǂ | |||
---|---|---|---|---|---|
Placebo | Varenicline | Difference | Cohen’s d | Ƞ2p | |
BL | 39.7 (26.3,53.0) | 31.7 (20.8,42.7) | -- | -- | |
4 | 21.4 (14.9,28.0)* | 20.1 (13.2,27.0)* | 1.4 (−8.2,10.9) | 0.06 | -- |
5 | 20.9 (14.3,27.6)* | 17.4 (10.5,24.2)* | 3.6 (−6.0,13.1) | 0.15 | -- |
6 | 18.8 (12.3,25.4)* | 13.8 (6.8,20.9)* | 5.0 (−4.7,14.6) | 0.21 | -- |
Overallƚ | 20.4 (14.5,26.2)* | 17.1 (10.9,23.3)* | 3.3 (−5.2,11.8) | 0.14 | 0.001 |
Values are noted as model-based means and associated 95% Confidence intervals adjusted for baseline values of CWS.
Overall treatment difference noted as the model based mean treatment effect during weeks 4–6 adjusted for baseline values.
Effect sizes are noted as Cohen’s d and are calculated using adjusted model based mean differences and pooled standard deviations. Partial eta squared values are presented for the overall main effect of treatment adjusted for baseline differences.
Notes significant within group changes from study baseline levels (p<.05).